door chiel@gcpcentral.com | jun 22, 2021 | GCP Central nieuws
De nieuwe Verklaring Geschiktheid Onderzoeksinstelling (VGO) in het kort Wat – De Verklaring Geschiktheid Onderzoeksinstelling (VGO) vervult in Nederland de rol van het site suitability formulier dat de EU nu vereist voor bepaalde onderzoeken door...
door GCP Central | jun 14, 2021 | GCP Central nieuws
Een interview met vice voorzitter van de werkgroep Lokale Uitvoerbaarheid, Astrid Schut. Voor alle STZ-ziekenhuizen, UMCs, algemene ziekenhuizen, universiteiten en onafhankelijke onderzoeksinstellingen in Nederland die WMO-plichtig onderzoek uitvoeren, alsmede...
door GCP Central | mrt 15, 2021 | GCP Central nieuws, GCP Central producten
With the constant increase of our e-learner base, we think of ways to accommodate your different learning and compliance needs. This is why we recently launched our new Refresher ICH GCP Course for Clinical Drug Trials in Germany. Our Refresher ICH GCP Course is...
door GCP Central | jan 26, 2021 | GCP Central nieuws, GCP Central producten
With the start of the new year, we launched our new Good Manufacturing Practice (GMP) online course that covers the legal requirements and best practices for quality oversight on external manufacturing. The GMP quality oversight course for European drug products is a...
door GCP Central | dec 23, 2020 | myGCP Software Release
In our ongoing commitment to high-quality GCP training, as well as providing you with the latest updates available, myGCP will undergo a software update on January 15, 2021. Read on to discover what’s new in myGCP version 2.11 User Friendly We’ve...
door GCP Central | dec 7, 2020 | GCP Central nieuws, GCP Central producten
Announcing the latest addition to the GCP Central online course offerings: Expert ICH GCP Course for Sponsors in International Clinical Trials. Our newest course is based on the Sponsors’ responsibilities, as documented in Section 5 of ICH GCP E6(R2). Explicitly...
